🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Human papillomavirus (HPV) infection has been established as a necessary ca...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-02
Trial ID
NCT00492544
Treatments Being Tested
This Post Marketing Surveillance (PMS) will collect safety data on the use ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01101542
Treatments Being Tested
The KEN SHE Study aims to identify effective cervical cancer prevention str...
Status
Unknown
Location
Partners in Health, Research and Development
Start Date
2018-12-19
Trial ID
NCT03675256
The main aim of this vaccine is to prevent cervical cancer in women. Howeve...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-05
Trial ID
NCT00309166
Treatments Being Tested
The purpose of this study was to assess the safety and reactogenicity of GS...
Status
Terminated
Location
GSK Investigational Site
Start Date
2008-09-17
Trial ID
NCT00730847
Treatments Being Tested
The study will be extended for subjects who received all three doses of vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06
Trial ID
NCT00337818
Treatments Being Tested
The purpose of this study is to establish the long-term persistence of the ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02100618
Treatments Being Tested
Six identical female twins aged 9-13 years will participate. One sib of eac...
Status
Completed
Location
Ghent University Hospital
Start Date
2013-06-25
Trial ID
NCT01914367
The purpose of this study is to evaluate the immunogenicity and the safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-11-21
Trial ID
NCT01462357
This is an observational cohort study to assess the risk of autoimmune dise...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT01953822
Treatments Being Tested